MarketCapTrends
LAB

Standard Biotools Inc. (LAB)

NASDAQ · Healthcare

Standard Biotools Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Standard Biotools Inc. shareholder equity for the quarter ending December 31, 2025 were 424.3M, a 10.05% decrease year-over-year.
  • Standard Biotools Inc. shareholder equity for 2025 were 424.3M, a 10.05% decrease from 2024.
  • Standard Biotools Inc. shareholder equity for 2024 were 471.7M, a 418.62% decrease from 2023.
  • Standard Biotools Inc. shareholder equity for 2023 were -148.1M, a 81.73% increase from 2022.
  • Standard Biotools Inc. shareholder equity for 2022 were -81.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Standard Biotools Inc. Annual Shareholder Equity (Millions of US $)
2025$424
2024$472
2023$-148
2022$-81
2021$95
2020$139
2019$154
2018$72
2017$31
2016$53
2015$115
2014$150
2013$96
2012$101
2011$57
Standard Biotools Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$424
2024-12-31$472
2023-12-31$-148
2022-12-31$-81
2021-12-31$95
2020-12-31$139
2019-12-31$154
2018-12-31$72
2017-12-31$31
2016-12-31$53
2015-12-31$115
2014-12-31$150
2013-12-31$96
2012-12-31$101
2011-12-31$57
2010-12-31$-189

Standard Biotools Inc. Shareholder Equity — FAQ

Standard Biotools Inc. (LAB) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LAB's shareholder equity history?

The chart and table above show Standard Biotools Inc.'s shareholder equity by year and by quarter, including the growth rate.